On Biz Buzz | Cipla CEO Exclusive, game changing moves in approvals and discovery

Updated : Oct 01, 2021 13:33
|
Editorji News Desk

The pandemic has led to a faster process in rolling out the right drug into the market, as pointed out by Umang Vohra, Global CEO & MD of Cipla.

In an exclusive conversation with Editorji and Fortune India, Vohra mentioned that data science and technology are allowing to match a prediction with the evidence really quickly.

"What took years to put together in terms of computational power, now just takes 10% of the time," Cipla's Global CEO told Editorji.

 

CiplaDrugvaccine

Recommended For You

Trump Wins US Election: How Trump 2.0 Could Impact India-US Relations, Vikram Chandra Decodes
editorji | Editorji specials

Trump Wins US Election: How Trump 2.0 Could Impact India-US Relations, Vikram Chandra Decodes

Labour leader Keir Starmer to be UK's new PM, vows to reset ties with India| Editorji Rewind
editorji |

Labour leader Keir Starmer to be UK's new PM, vows to reset ties with India| Editorji Rewind

editorji | Editorji specials

Modi factor or rural distress: Uttar Pradesh faces key election decision before phase 7| The India Story

editorji |

Women voter participation has increased in 2024. Are political parties taking note? | The India Story

editorji | Editorji specials

NDA or INDIA bloc: Yashwant Deshmukh on who will win on June 4| The India Story: Road to 2024